To confirm the expression of monocarboxylate transporters (MCT) 1, 2, and 4 in rabbit CE and to test the hypothesis that cellular buffering contributed by HCO 3 -, NBCe1, and carbonic anhydrase (CA) activity facilitates lactate-H + efflux thereby controlling corneal hydration in vivo.
METHODS. MCT1-4 expression of rabbit endothelium was examined by Western blotting and immunofluorescence staining. Lactate-induced acidification (LIA) was measured in perfused CE in the presence and absence of HCO 3 -and acetazolamide (ACTZ) using tissue treated with siRNA specific to MCT1, 2, and 4. Corneal thickness and lactate concentration were measured in New Zealand White rabbits treated with the topical CA inhibitor Azopt, and from eyes that were injected intracamerally with ouabain, disodium 4,4 0 -diisothiocyanatostilbene-2,2 0 -disulfonate (DIDS), and shRNA specific to the 1Na + :2HCO 3 -cotransporter NBCe1.
RESULTS. MCT1 and MCT4 are localized to the lateral membrane, while MCT2 is apical. Cell pH measurements showed LIA in response to 40 mM lactate in bicarbonate free (BF) Ringer's that was inhibited by niflumic acid and by MCT siRNA knockdown, and significantly reduced in the presence of HCO 3 -. Lactate-dependent proton flux in vitro was not significantly greater in the presence of HCO 3 -or reduced by ACTZ. However, when active transport, NBCe1, or CA activity was disrupted in vivo, corneal edema ensued and was associated with significant corneal lactate accumulation.
CONCLUSIONS. MCT1, 2, and 4 are expressed in rabbit CE on both the apical and basolateral surfaces and function to transport lactate-H + . Lactate-H + flux is facilitated by active transport, HCO 3 -transport and CA activity, disruption of which causes corneal edema in vivo and indicates that facilitation of lactate efflux is a component of the endothelial pump. (Invest Ophthalmol Vis Sci. 2012;53:2020-2029) DOI:10.1167/iovs. T he corneal endothelium plays an essential role in maintaining corneal hydration and transparency. Fluid is passively imbibed into the cornea driven by the stromal swelling pressure that is generated by the negatively charged stromal glycosaminoglycans. This passive fluid influx or ''leak'' is offset by an outward active ''pump,'' located within the corneal endothelium, thereby maintaining corneal hydration and transparency. A breakdown in the pump function (e.g., corneal endothelial dystrophies, anterior uveitis, or trauma) will lead to corneal edema, increased light scatter, and loss of visual function.
The endothelial pump function is the composite of plasma membrane primary and secondary active transport phenomena. The pump is blocked by the Na + /K + -ATPase inhibitor ouabain [1] [2] [3] and is slowed in the absence of bicarbonate [4] [5] [6] [7] and in the presence of carbonic anhydrase inhibitors, [4] [5] [6] 8, 9 suggesting the presence of a Na-dependent HCO 3 -linked secretory mechanism. Studies have shown the presence and activity of basolateral (stromal side) Na Cl -/HCO 3 -exchange, [16] [17] [18] and Na + /H + exchange. 12, 16 However on the apical (aqueous humor facing) membrane there is no evidence of Na + or Cl -linked HCO 3 -transport. 17, 19, 20 Regulated (Ca 2+ or cAMP) apical anion channels are present but do not contribute to basal pump activity. 21, 22 A recent review of the endothelial pump concludes that evidence for an HCO 3 -dependent secretory pump is lacking. 23 24 Eighty-five percent of the glucose taken up by the cornea is converted to two lactate molecules, 25 which represents a net osmotic load. Moreover, lactate is a potent osmolyte in the cornea since additional production of lactate (e.g., during corneal hypoxia) will lead to corneal edema. 26 This indicates that efficient removal of lactate is essential in maintaining corneal hydration and suggests that cellular buffering contributed by HCO 3 -, HCO 3 -transporters, and CA activity could be a significant component of the endothelial pump. Based on these findings, we wanted to test this hypothesis in an in vivo rabbit model. We expect that disrupting any component of the bicarbonate-carbon dioxide buffering system in vivo will lead to stromal lactate accumulation and consequently to corneal edema.
In this study, we examined the role of buffering capacity in the transport of lactic acid in Descemet's-endothelium explants ex vivo and in vivo. First, we confirmed that MCT isoforms are expressed in the rabbit endothelium and determined their membrane localization. We then examined the effect of HCO 3 -and CA activity on buffering capacity and lactate-induced cell acidification (LIA) in freshly dissected rabbit Descemet's-endothelium explants. Last, we tested the hypothesis that disrupting any component of the bicarbonate-carbon dioxide buffering system in vivo will lead to stromal lactate accumulation and consequently corneal edema.
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MATERIALS AND METHODS

Immunoblotting
New Zealand White rabbit eyes were obtained from Pel-Freez Biologicals (Rogers, AR), shipped overnight on ice, and used within 24 to 36 hours following death. Corneal scleral skirts were excised from the eyes, and the endothelium was peeled using a fine-tip forceps under a dissecting microscope. The endothelium was disrupted with RIPA lysis buffer solution (50 mM Tris base, 150 mM NaCl, 0.5% deoxycholic acid-sodium salt, 2% SDS and 1% NP40, pH 7.5, protease inhibitor cocktail) and sonicated (Branson 250, Branson Ultrasonics, Danbury, CT) on ice. This was followed by centrifugation at 14,000g for 15 minutes to pellet cell debris. The supernatant was collected, and an aliquot was taken for protein concentration measurement using the Pierce BCA Protein Assay (Thermo Fisher Scientific, Waltham, MA). Laemmli sample buffer (1·) was added to 15 lg protein samples, and the mixture was heated in a 958C heating block for 5 minutes to denature the protein. Samples were resolved on 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). Blots were then probed with MCT1, 2, 3, or 4 polyclonal antibodies (sc-50325; sc-50323; sc-14930; and sc-50329; respectively, 1:1000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) for 1 hour at room temperature. Secondary horseradish peroxidase conjugated antibody incubation was done for 1 hour at room temperature (1:5000 dilution). Bound antibody was detected using Supersignal West Pico Chemiluminescent substrate (Pierce, Thermo Fisher Scientific).
Immunofluorescence
Immunofluorescence staining was performed on freshly peeled corneal endothelium that was placed with the apical surface up on a glass microscope slide and fixed with PLP fixation buffer solution (2% paraformaldehyde, 75 mM lysine, 10 mM sodium periodate, and 45 mM sodium phosphate, pH 7.4) at room temperature for 20 minutes. Rabbit anti-MCT1, MCT2, and MCT4 polyclonal antibodies were diluted 1:50 in equal mixture of PBS-goat serum and applied to slides at room temperature for 1 hour. Goat anti-MCT3 polyclonal antibody was diluted 1:100. Coverslips were washed three times for 15 minutes in PBS containing 0.01% saponin. Then, secondary antibody, Alexa 488 anti-rabbit for MCT1, MCT2, and MCT4 and Alexa 488 anti-goat for MCT3 were applied for 1 hour at room temperature (1:1000 dilution). Slides were washed, nuclei counterstained with DAPI, and mounted with Prolong antifade medium (Molecular Probes, Invitrogen Life Technologies, Carlsbad, CA). Fluorescence was observed with an epifluorescence microscope equipped with a cooled charged couple device (CCD) camera.
Measurement of Intracellular pH
A corneal scleral skirt was dissected and used to trephine a 10-mm corneal button. The button was loaded with the pH-sensitive fluorescent dye 2 0 7 0 -bis(2-carboxyethel)-5(6)-carboxyfluorescein (BCECF) by incubation in HCO 3 -free Ringer's solution containing 1 to 5 lM BCECF-acetoxymethyl (AM) at room temperature for 30 minutes. BCECF-AM was removed and replaced with HCO 3 -free Ringer's solution for at least 30 minutes before use. The corneal endothelium was peeled from the button and placed onto a 13-mm diameter, 45-lm thick, 0.2-lm-pore diameter, rigid Anodisc filter (Whatman, Kent, UK) and mounted in a double-sided perfusion chamber. 17 Fluorescence was excited alternately at 495 -10 nm and 440 -10 nm. Fluorescence emission (520-550 nm) ratios (F 495 /F 440 ) obtained at 1 Hz were calibrated against pH i by the high-K + -nigericin technique. 12, 17 The assembled perfusion chamber was placed on a water-jacketed (378C) brass collar held on the stage of an inverted microscope (Diaphot 200; Nikon, Tokyo, Japan) and viewed with a long working distance (2 mm) water-immersion objective (40·; Nikon). Apical and basolateral compartments were connected by tubing (Phar-Med; Saint-Gobain Performance Plastics, Paris, France) to hanging syringes that contained Ringer's solution in a warming box (378C). The flow of the perfusate (approximately 0.5 mL/min) was achieved by gravity. Two independent eight-way valves were used to select the desired perfusate for the apical and basolateral chambers. We used Felix32 (Photon Technology International, Birmingham, NJ) software to analyze the pH i change. The initial rate of pH i change taken over the first 20 seconds was used to determine dpH i /dt. The rate of acidification is expressed as pH i /s, and the degree of acidification was determined by the amount of change in pH i and is expressed as DpH i .
Ringer's Solutions and Chemicals
The composition of the standard bicarbonate-free Ringer's solution used throughout this study was (in millimoles) 150 Na + , 4 K + , 0.6 Mg 2+ , 1.4 Ca 2+ , 118 Cl -, 1 HPO 2 4 -, 10 HEPES, 28.5 gluconate -, and 5 glucose. Bicarbonate-rich Ringer's solution was prepared by equimolar substitution of sodium gluconate with NaHCO 3 -(28.5 mM). Ringer's solutions were equilibrated with air (BF) or 5% CO 2 (BR), and pH was adjusted to 7.5 with NaOH at 378C. Lactate solutions were prepared on the morning of the experiment by equimolar substitution of Na + -gluconate by the Na + -salt of L(+) lactate. Osmolarity of all solutions was adjusted to 295 to 300 mOsm by adding sucrose. Sodium L(+) lactate, niflumic acid, disodium 4,4 0 -diisothiocyanatostilbene-2,2 0 -disulfonate (DIDS), ouabain, and acetazolamide (ACTZ) were obtained from Sigma Aldrich (St. Louis, MO). BCECF-AM was purchased from Molecular Probes.
MCT Knockdown Ex Vivo
MCT1, 2, and 4 specific siRNAs were purchased from Santa Cruz Biotechnology (Catalog Nos.: MCT1, sc-108031; MCT2, sc-108032; and MCT4, sc-108033). Ex vivo cornea cultures were established by the following procedure. New Zealand White rabbit eyes were sterilized with 1% povidone iodine for 1 minute and rinsed with sterile PBS. A corneal scleral skirt was excised aseptically and washed with sterile PBS, then placed in a sterile six-well plate with adaptations that allow the tissue to sit upright and remain cupped. MCT 1, 2, or 4 siRNA was added along with lipofectamine 2000 in 100 lL OPTI-MEM (Gibco, Invitrogen, Grand Island, NY) to the endothelial surface and incubated for 6 hours at 378C, 5% CO 2 -95% air. The transfection medium was removed, and the tissue was placed in a sterile 12-well plate and immersed with 2 mL Dulbecco Modified Eagle Medium (DMEM), 10% bovine calf serum (BCS) and 1% antibiotic/antimycotic (100 U/mL penicillin and 0.25 ug/mL Fungizone). The medium was changed twice a day. Seventy-two hours post transfection, the endothelium was peeled and LIA was measured. A nontargeting siRNA (Dharmacon, Thermo Fisher Scientific) was used as negative control. 
Experimental Animals
Intracameral Injection of Pharmacologic Inhibitors
After sedating the rabbit, two drops of 0.5% proparacaine HCl were topically applied to the eye. With the aid of an ophthalmic surgical microscope, 25 lL of 1-mM ouabain or 25 lL of 10-mM DIDS was injected into the anterior chamber of the left eye using a 30-gauge needle on a Hamilton glass syringe (Hamilton Company, Reno, NV). The right eye was injected with 25 lL sterile PBS. The needle was inserted perpendicular to the corneal surface 1 to 2 mm from the limbus, and then while the tip was still in the stroma, turned and pointed toward the anterior-center of the anterior chamber. The inhibitor was slowly injected into the anterior chamber, and the needle was carefully removed from the cornea.
Central Corneal Thickness Measurements
CT measurements were made by ultrasound pachymetry (DGH Technology, Exton, PA). Two drops of proparacaine were topically applied on the corneas of unsedated rabbits. Baseline corneal thickness measurements were made before injection of the pharmacologic inhibitors or viral particles. Subsequently, after injection with the pharmacologic inhibitors, CT measurements were made hourly until peak CT was obtained (between 5 and 7 hours). CT measurements were made weekly on eyes injected with viral particles.
NBCe1 In Vivo Knockdown
Rabbits were injected intracamerally with the electrogenic sodium bicarbonate cotransporter (1Na + :2HCO 3 -) shRNA (NBCe1; SLC4a4) as part of a previous study. 27 The eyes transfected with NBCe1 shRNA that had greater than 25% knockdown after 2 to 4 weeks were used to examine the association between corneal edema and lactate concentration. Briefly, lentiviruses were used to deliver the NBCe1 and scrambled shRNA into the corneal endothelium. The details of the shRNA sequences, technique for lentivirus production, and anterior chamber injection have been previously described. 27 Baseline CT measurements were made prior to the intracameral injection and weekly post injection. Following euthanasia, the eyes were enucleated, and the corneal endothelium was peeled and subjected to Western blotting to determine efficiency of knockdown. The remaining cornea was used to analyze lactate concentration following the procedure described by Klyce 26 with some minor modifications. Briefly, a 10-mm central corneal button was trephined from the tissue and immediately placed in a mortar and submerged with liquid nitrogen for 1 minute to stop further metabolism. With a steady stream of liquid nitrogen pouring over the tissue, it was pulverized using a pestle. The sample was then transferred to an Eppendorf tube (Eppendorf, Hauppauge, NY) filled with 1 mL PBS, centrifuged at 1700g for 15 minutes, and the supernatant collected for lactate analysis. The pellet was used to determine protein concentration. One-hundred microliters RIPA lysis buffer was added to the pellet and sonicated on ice. This was followed by centrifugation at 14,000g for 15 minutes to pellet cell debris. The supernatant was collected, and an aliquot was taken for protein concentration measurement using the Pierce BCA Protein Assay (Thermo Scientific).
Statistical Analysis
Data analysis is presented as mean values -standard error. Paired t-test was used for statistical analysis and P < 0.05 was considered significant.
RESULTS
As previously reported for the bovine corneal endothelium, 24 Western blotting confirmed that MCT1, MCT2, and MCT4 are expressed in the rabbit corneal endothelium (Fig. 1A) . Similar to bovine, MCT3 was not expressed. Immunofluorescent staining localized MCT1 and MCT4 to the basolateral and MCT2 to the apical surface (Fig. 1B) . To test if MCTs are functional in the rabbit corneal endothelium, we measured the amount of acidification during 1-minute exposure to 40 mM lactate on the BL surface in the absence and presence of 100 lM niflumic acid, a nonspecific MCT inhibitor (Fig. 1C) . Niflumic acid on the BL surface in BF Ringer's solution reduced the rate of LIA by 57% (n = 6, P = 0.0008) and amount of LIA by 41% (n = 6, P = 0.0007) (Fig. 1D) .
To further confirm that MCTs are directly involved in transporting lactate-H + , LIA was measured 72 hours after siRNA knockdown of MCT1, MCT2, and MCT4 collectively within ex vivo cultured corneas. Maximum knockdown of MCT1 was achieved with 200 nM siRNA (62% knockdown) and MCT4 and MCT2 with 100 nM siRNA (83% and 16% knockdown, respectively) ( Figs. 2A-C) . Intracellular pH was determined in CE that was treated with a combination of MCT1, MCT2, and MCT4 siRNAs and on CE treated with scrambled siRNA. Twenty millimolar lactate pulses in BF Ringer's solution were simultaneously given on both the apical and basolateral surfaces for 25 seconds. Compared with cells treated with scrambled siRNA, the rate of acidification was slowed by 55% in cells treated with MCT siRNAs (n = 8, P = 0.002), and the amount of acidification was reduced by 78% (n = 8, P = 0.0002) (Fig. 2D) , indicating that the MCTs are responsible for LIA. When lactate was perfused only on the BL surface in cells treated with MCT siRNAs, there was no LIA (data not shown), consistent with the much greater knockdown of the basolateral MCT1 and 4.
Previously, we demonstrated that bicarbonate and carbonic anhydrase enhanced lactate-H + cotransport in cultured bovine corneal endothelial cells (CEC). 24 We attributed the facilitated transport to increased intracellular buffering capacity. To determine if this mechanism was also significant in rabbit endothelium, we first examined the effect of bicarbonate on lactate-induced acidification. In the absence of bicarbonate, there was significant acidification when 20 mM lactate was perfused for 1 minute on either the apical or basolateral surface (Fig. 3A) . However, in the presence of bicarbonate, the amount of acidification was significantly less on the basolateral surface and unmeasurable on the apical surface (Fig. 3A) . Next, we decreased intracellular buffering by incubating the tissue in 100 lM acetazolamide, a carbonic anhydrase inhibitor. Acetazolamide did not change the rate of LIA in tissues perfused without bicarbonate (0.00167-0.00163 pH units/sec, n = 5, P = 0.57) (Fig. 3B) . However, in the presence of bicarbonate, acetazolamide produced a small, but significant increase in the rate of LIA on the BL surface (from 0.0006 to 0.0008 pH units/sec, n = 8, P = 0.03) (Fig. 3B) . To determine if lactate-dependent proton flux (J H + [mM/sec] = b T *dpH i /dt) was affected by HCO 3 -or ACTZ, total buffering capacity (b T = b i + b HCO3 ) was determined under each condition as previously described. 12, 24 The intrinsic buffering capacity (b i = 20 mM/pH) of the rabbit endothelium was determined using dpH i /dt of the first 20 seconds following exposure to NH 4 Cl. 12 We found that b HCO3 (= 2.303 * [HCO 3 -] i ) 28 was reduced by 43% in the presence of ACTZ. This relative reduction in buffering was experimentally determined by measuring the change in pH i during a pulse of 2 mM NH 4 Cl in the absence and presence of 100 lM ACTZ in BR Ringer's solution (data not shown). Although the rate of LIA was significantly smaller in BR Ringer's solution, with the increased buffering supplied by bicarbonate, lactate-dependent proton flux was 13% greater; however, this was not significant (P > 0.05; Table 1 ). Table 1 also shows that ACTZ had no effect on lactate-dependent proton flux in the absence of HCO 3 -as expected; however, in the presence of HCO 3 -proton flux decreased by 6%, but again not significant (P > 0.05). So, unlike the cultured bovine corneal endothelium, 24 we could not demonstrate significant HCO 3 -/CA-facilitated lactate-dependent H + fluxes in vitro in the rabbit endothelium. A major difference is that the rate of LIA in the rabbit endothelium is more than 10-fold smaller (e.g., dpH/sec = 0.011 in bovine cells and 0.0008 in rabbit in BR + ACTZ), which significantly limits the ability to resolve differences. Therefore, we next explored disruption of HCO 3 -buffering using an in vivo approach.
If the components of the cellular buffering system facilitate the removal of lactate in vivo, then disrupting the function of these components will lead to slower clearance of lactate from the cornea and accumulation of stromal lactate will produce corneal edema. Hence, we disrupted components of the cellular buffering system using pharmacologic inhibitors and/ or shRNA, and measured the change in corneal thickness and corneal lactate concentration. First, we predict that inhibiting the sodium-potassium ATPase, which produces the cell membrane Na + gradient that drives secondary active transporters such as Na + :2HCO 3 -cotransport and Na + /H + exchange will affect lactate removal. Ouabain (25 lL, 1 mM) was injected intracamerally in one eye of seven rabbits, and the other eye received 25 lL PBS. Corneal swelling was noted in all ouabain-injected eyes peaking at approximately 5 hours. No change in corneal thickness was noted in the control eyes. The mean corneal swelling response was 23% -3%. Eyes injected with ouabain showed a significant 1.82-fold increase in corneal [lactate] (Fig. 4A , P = 0.02). There was a moderate correlation (r = +0.57) between the extent of corneal swelling and [lactate] in eyes treated with ouabain, although this correlation was not significant, P > 0.05 (Fig. 4A ). Previously, we had shown that two drops of the topical CA inhibitor Azopt (1%, brinzolamide ophthalmic suspension [Alcon, Fort Worth, TX]) caused corneal swelling in the rabbit. 27 Azopt produced 6% -0.006% corneal swelling at 3 hours and a significant 1.43-fold increase in corneal lactate concentration (n = 7, P = 0.01) relative to control eyes (Fig.  4B) . However, the correlation between the extent of corneal swelling and [lactate] in eyes treated with Azopt was weak (r = +0.22, P > 0.05; Fig. 4B ).
Next, we examined the role of HCO 3 -transport in facilitating lactate-H + cotransport in vivo. We disrupted the basolateral Na + :2HCO 3 -cotransporter using the nonspecific anion transport inhibitor DIDS or via NBCe1 shRNA delivered intracamerally with lentiviruses. Relative to the PBS-injected eyes, DIDS-treated eyes showed 22% -2% corneal swelling at 5 hours and a significant 1.25-fold greater corneal [lactate] compared with the untreated eye (n = 6, P = 0.03) (Fig. 5A ). There was a moderate (r = +0.50), but not statistically significant (P > 0.05), correlation between corneal swelling and [lactate] in eyes treated with DIDS (Fig. 5B) . Of the 11 rabbits injected with NBCe1 shRNA, 8 rabbits had >25% knockdown and were included in the analysis. Corneal [lactate] was significantly increased by two-fold in the NBCe1 knockdown eyes (Fig. 6A, P < 0.05 ). There was a strong correlation (r = +0.81, P < 0.01) between corneal swelling and [lactate] (Fig. 6B) . Mean acidification rates and the mean change in pH i (n = 6) -SEM due to lactate. Rates were determined over the first 20 seconds. The mean rate was reduced by 57%, and LIA was decreased by 41% in the presence of niflumic acid. * Significantly lower than control (P < 0.05).
DISCUSSION
In the current study, we determined that MCT 1, 2, and 4 are expressed in the rabbit corneal endothelium on apical and basolateral membranes. The MCTs function to move lactate coupled to a H + in a direction determined by the sum of the chemical gradients. The lactate concentration gradient from stroma (approximately 14 mM) to anterior chamber (approximately 7 mM) 26 is 2, and the proton gradient is variable, but in the same direction, 29, 30 Therefore, the MCTs will facilitate lactate efflux across the endothelium to the anterior chamber. The presence of bicarbonate and CA activity significantly buffers pH i , but in contrast to cultured CE, 24 we showed only a modest facilitation of lactate:H + cotransport in vitro. On the other hand, disruption of active transport, pHi regulation and buffering in vivo via inhibition of sodium-potassium ATPase, carbonic anhydrase, or Na + :2HCO 3 -cotransporter produced significant corneal edema and stromal lactate accumulation.
Of interest, the MCT expression pattern in rabbit endothelium was slightly different from cultured bovine CE. 24 In rabbit, MCT1 and 4 were basolateral and MCT2 apical. Whereas in bovine, MCT4 was apical and MCT2 basolateral. 24 MCT4 has a basolateral sorting signal in the C-terminal portion of the cytoplasmic tail. 31 Nevertheless, some studies show that MCT4 can localize to the apical membranes in certain tissues. 32, 33 Even in the same organ (e.g., small and large intestine), the expression profile of MCT4 varies depending on the region. 33 It has also been reported that MCT expression in a tissue can vary among different animal species. 34 This may be related to differential expression of the needed chaperones between bovine and rabbit endothelium. 35, 36 Further studies are needed to understand these discrepancies.
As in our previous study, 24 we show that niflumic acid, a well-described inhibitor of MCTs, 37 inhibits LIA. Niflumic acid is nonspecific and has been shown to also inhibit anion channels, specifically Cl -channels leading to membrane hyperpolarization. 38 However, lactate:H + cotransport is electroneutral, so a secondary effect on lactate-coupled proton influx is remote. In our experiment, we compared the acidification of cells in response to a lactate pulse in the absence and presence of niflumic acid. We showed a significant inhibition of acidification, which is consistent with niflumic acid's known inhibitory action on MCTs. AstraZeneca (Wilmington, DE) has developed compounds that show very specific inhibition of MCT1 and 4; however, these compounds are currently unavailable (A. Halestrap, written communication, 2011).
To provide direct and specific evidence for the action of MCTs in rabbit endothelium, siRNAs were used to silence MCT1, 2, and 4 in ex vivo corneas. Although we did not achieve complete knockdown of the MCTs, we were able to reduce expression of all three MCTs and show corresponding reduction in LIA when we perfused with lactate on both the basolateral and apical surfaces simultaneously (Fig. 2D) . However, when lactate was perfused only on the BL surface, there was no LIA, indicating that the observed LIA in cells treated with the siRNAs was predominantly via apical lactate-H + cotransport from MCT2, which was knocked down by only 16%. In sum, these experiments demonstrate that MCTs are responsible for lactate-induced acidification. Previously we had shown that bicarbonate buffering and carbonic anhydrase activity facilitate lactate:H + cotransport in cultured bovine corneal endothelial cells. 24 Moreover, other studies have shown that MCT-dependent lactate-H + flux is facilitated by bicarbonate transporters and carbonic anhydrase (CA) activity in various cells and tissue. [39] [40] [41] [42] [43] [44] [45] Here, we found that LIA in freshly dissected rabbit CE was more than 10-fold less than in bovine cells in bicarbonate-free conditions and approximately 30-fold less in bicarbonate-rich Ringer's solution. Total buffering capacity in rabbit CE is only slightly greater than cultured bovine endothelium, indicating that overall lactate:H + fluxes are much less in the fresh rabbit CE, making it difficult to examine the effects of buffering on lactate:H + cotransport by measuring changes in pH i . Although the effects of bicarbonate and CA activity on enhancing lactatedependent proton fluxes were modest in vitro (Table 1) , the effects in vivo were quite striking.
Our hypothesis states that lactate:H + efflux is an osmotic component of the endothelial pump and that transendothelial flux is facilitated by intracellular and extracellular cellular buffering as illustrated in Figure 7 . In vivo, we used four approaches to disrupt the components of the buffering system: intracameral injection of ouabain to inhibit the Na + -K + ATPase, DIDS injection to inhibit anion transport including Na + :2HCO 3 -cotransport, NBCe1 shRNA to directly reduce Na + :2HCO 3 -expression and cotransport activity, and topical (Fig. 4A) . Figure 4A shows that increasing corneal swelling was associated with increasing stromal [lactate], but the correlation was not statistically significant. Azopt, on the other hand, produced a much smaller, but still significant increase in CT (approximately 6%-8%). Again, swollen corneas had significantly more lactate; however, a direct correlation between change in CT and [lactate] could not be established. Similarly, DIDS induced significant corneal swelling and an increase in [lactate], but moderate correlation. Last, NBCe1 shRNA knockdown significantly increased CT and [lactate]. In contrast, there was a significant correlation between the change in CT and the increased [lactate] . In sum, all four approaches demonstrated a significant increase in corneal thickness and lactate concentration relative to control eyes. In most, there was an apparent association between the degree of swelling and increased [lactate] . Whereas the acute experiments could not establish a significant correlation between swelling and [lactate], the chronic NBCe1 knockdown experiment did.
Corneal swelling can be produced by either inhibition of the pump or an increase in endothelial hydraulic conductivity (i.e., decreased barrier function). If the acute injections of inhibitors decrease barrier function (e.g., disruption of tight junctions), then swelling unrelated to the pump will occur. Possible disruption of barrier function could not be a result of the injections themselves, since the controls did not swell significantly. We do not expect ouabain or DIDS to disrupt barrier function; however, we used relatively high concentrations to offset dilution by aqueous humor. Variable mixing following injection could expose the endothelium to the high concentrations that may have an effect on monolayer integrity. Similarly, topical Azopt is not expected to disrupt barrier function. However, the small amount of swelling with Azopt suggests that much larger numbers of experiments will be needed to show a correlation. If these approaches are used in the future, barrier function will need to be determined. [46] [47] [48] We suspect that the knockdown approach is more robust in showing this relationship because any possible effects of injection solutions on barrier integrity are likely resolve over the weeks.
In summary, our results show that bicarbonate, bicarbonate transporters, and CA play a role in facilitating the clearance of lactate from the corneal stroma into the aqueous humor. Failure to efficiently remove lactate from the cornea will lead to corneal edema. Thus, the transport of lactate-H + is a significant component of the endothelial fluid pump. It is possible that lactate rather than HCO 3 -is the key ion that drives the endothelial fluid pump. This would be consistent with previous studies 6, 7, [49] [50] [51] that show the endothelial fluid pump can still function in the absence of bicarbonate while in the presence of high buffer concentration. Further studies are needed to explore this link between lactate flux and fluid secretion in the corneal endothelium. -] is provided by robust basolateral NBCe1 activity. Buffering of the lactate-dependent H + influx or direct removal by Na + /H + exchange prevents H + accumulation and slowing of further lactate:H + influx. Efflux of lactate:H + at the apical membrane is provided by MCT2. Apical CA IV catalyzes buffering of ejected protons within the unstirred apical layer of the anterior chamber where HCO 3 -is readily available.
